Zydus Cadila seeks nod to repurpose Hepatitis C drug for Covid-19 in India | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Monday
May 26, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
MONDAY, MAY 26, 2025
Zydus Cadila seeks nod to repurpose Hepatitis C drug for Covid-19 in India

Coronavirus chronicle

Reuters
05 April, 2021, 12:40 pm
Last modified: 05 April, 2021, 12:47 pm

Related News

  • Aid funding disrupts child vaccinations almost as much as pandemic: UN
  • Trump's White House launches COVID website that criticizes WHO, Fauci and Biden
  • Chinese researchers find bat virus enters human cells via same pathway as Covid
  • Forgotten but not gone: Covid keeps killing, five years on
  • Another pandemic is inevitable, and we're not ready

Zydus Cadila seeks nod to repurpose Hepatitis C drug for Covid-19 in India

According to the company, 91.15% of patients treated with Pegylated Interferon Alpha 2b, PegiHepTM were RT-PCR negative by day seven, as compared to 78.90% on the standard of care arm in its phase 3 trials

Reuters
05 April, 2021, 12:40 pm
Last modified: 05 April, 2021, 12:47 pm
Eli Lilly and Regeneron Pharmaceuticals Inc. are asking the US government to allow emergency use of their antibody drugs, which aim to help the immune system clear the virus. Photo: AP
Eli Lilly and Regeneron Pharmaceuticals Inc. are asking the US government to allow emergency use of their antibody drugs, which aim to help the immune system clear the virus. Photo: AP

 India's Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for Covid-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.

A single dose of the Hepatitis C drug when taken early could help Covid-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said in a statement to stock exchanges.

About 91% of patients treated with the drug tested negative for Covid-19 in standard RT-PCR tests by day seven, compared to nearly 79% who were given the standard of care, the company said citing Phase-III clinical trial data.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The drug, known as Pegylated Interferon alpha-2b and branded as 'PegiHep' by Cadila, was originally approved for liver disease Hepatitis C and launched in India 10 years ago. It is being repurposed to treat Covid-19.

The news comes as daily coronavirus infections are surging to new highs in India, which has the world's third-highest caseload after the United States and Brazil. India has so far reported close to 12.5 million infections and more than 164,000 deaths.

Zydus Cadila / hepatitis drug / Covid-19 treatment / Covid / Covid -19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Showkat Aziz Russell, Anwar-ul Alam Chowdhury Parvez, Razeeb Haider. Photos: Collected
    Business leaders decry 'economic assassination' amid crippling gas crisis
  • A BNP delegation led by senior leader Khandaker Mosharraf Hossain meets with Chief Adviser Muhammad Yunus during a meeting at Guest State House Jamuna on 24 May 2025. Photo: CA Press Wing
    Stalemate over election: Resolving or deepening?
  • Chief Adviser Muhammad Yunus. File Photo: CA Press Wing
    CA meeting with BNP, Jamaat, NCP and 20 others: What was said

MOST VIEWED

  • Infographic: TBS
    New transport strategy for Dhaka seeks to promote walking, cycling
  • Representational image: Collected
    Minimum tax may rise to Tk5,000 for individuals, Tk1,000 for new filers
  • File photo of Sajib Barai. Photo: TBS
    Barishal medical student ends life after citing 'excessive academic pressure'
  • FIre service officials taking the bodies after a truck hitting a motorcycle in Banani left two people killed on the spot on 25 May 2025. Photo: TBS
    2 killed after truck hits motorcycle in Banani
  • Ports crippled as NBR officials escalate protests, threaten full trade halt
    Ports crippled as NBR officials escalate protests, threaten full trade halt
  • BNP senior leaders and CA at Jamuna on 24 May evening. Photo: CA Press Wing
    Talks with CA: BNP calls for swift completion of reforms for elections in Dec, removal of 'controversial' advisers

Related News

  • Aid funding disrupts child vaccinations almost as much as pandemic: UN
  • Trump's White House launches COVID website that criticizes WHO, Fauci and Biden
  • Chinese researchers find bat virus enters human cells via same pathway as Covid
  • Forgotten but not gone: Covid keeps killing, five years on
  • Another pandemic is inevitable, and we're not ready

Features

The Hili Land Port, officially opened in 1997 but with trade roots stretching back to before Partition, has grown into a cornerstone of bilateral commerce.

Dhaka-Delhi tensions ripple across Hili’s markets and livelihoods

3h | Panorama
Photo: Collected

Desk goals: Affordable ways to elevate your study setup

9h | Brands
Built on a diamond-type frame, the Hornet 2.0 is agile but grounded. PHOTO: Asif Chowdhury

Honda Hornet 2.0: Same spirit, upgraded sting

10h | Wheels
The well has a circular opening, approximately ten feet wide. It is inside the house once known as Shakti Oushadhaloy. Photo: Saleh Shafique

The last well in Narinda: A water source older and purer than Wasa

2d | Panorama

More Videos from TBS

27 wildlife rescued in mini zoo raid

27 wildlife rescued in mini zoo raid

2h | TBS Stories
How the small country in South America has become the subject of research.

How the small country in South America has become the subject of research.

2h | Others
All Israeli armored brigades are now deployed in Gaza

All Israeli armored brigades are now deployed in Gaza

3h | TBS World
India-Pakistan, China-Iran; Why is everyone pulling the Taliban closer?

India-Pakistan, China-Iran; Why is everyone pulling the Taliban closer?

3h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net